Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.

WaveLight AG produces laser-systems for optimizing medical procedures. The company's product is LASIK applications, which is used for eye operation. The company was founded by Maximilian Reindl on April 30, 1996 and is headquartered in Erlangen, Germany

Senju Pharmaceutical Beijing Co. Ltd., part of Senju Pharmaceutical Co., Ltd., is a company headquartered in Beijing, China, that manufactures and distributes pharmaceuticals.

Carl Zeiss Meditec AG engages in the development, manufacture and marketing of medical devices. It operates through the Ophthalmic Devices and Microsurgery business segments. The Ophthalmic Devices segment includes intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded on July 2002 and is headquartered in Jena, Germany.

IntraLase Corporation is a leader in the first step of LASIK surgery, the most common means of surgical vision correction. They design, develop and market a laser, related software and disposable devices used to create a cut of tissue across the cornea of a patient’s eye, or a corneal flap, which is the first step in LASIK surgery. Their advanced laser technology improves the safety, precision and visual acuity of LASIK surgery by providing a computer-controlled laser solution as an alternative to the traditional method of creating the corneal flap using a hand-held mechanical, metal-bladed device called a microkeratome. They believe their product offering will become the new standard of care for corneal flap creation. As of April 2, 2007, IntraLase Corp. was acquired by Advanced Medical Optics Inc.

Our company is located in the scenic paradise in Hangzhou, Which is a professional design/development/manufacturing and sales of electricity energy meter & power information collection system high-tech enterprises. We are one of the most promising in the energy measurement instrumentation industry of China. Appeared in the " Forbes " 2011,2012 China’s potential business list. We are high-tech enterprise with research and development centers in Zhejiang Province, with independent research and development of advanced MES manufacturing execution system. And Electric Instruments Branch of China Instruments Manufactures Association governing units. Involved in the drafting of number of power measuring instruments and standards revision. And also we are member of DLMS International Association. We have passed the ISO9001 quality management system, ISO14001 environmental management system, GB/T28001-2001 Occupational Health and Safety Management System and AAA level measurement management system certification, the CMC complete measurement license, China CCC quality certification, the Netherlands KEMA certification. The company has established a highly efficient and experienced R & D team, Which has more energy meter products patents and software copyrights. The R&D center built energy meter performance laboratories, environmental impact test chamber, electromagnetic compatibility (EMC) laboratory, structures and materials laboratories and multiple measurement test chamber. Which has advanced HAEFELY test equipment of Switzerland. to ensure top quality products. Products including smart energy meter, electronic meter, specifically variable terminal, distribution transformer terminal, concentrator and power information collection system, as well as smart energy meter according to IEC/ANSI standard, electronic energy meter series measurement products & software, accessories, and so on. Company to "Accurate Measurement, Serving for the society" for the mission. Adhering to the "Technology-first, quality and efficiency, customer-first, good faith compliance" concept. Efforts to serve the power industry, is committed to being first-class energy measurement instruments and systems supplier.

OptiMedica Corporation is a Silicon Valley-based global ophthalmic device company dedicated to developing performance-driven technologies that improve patient outcomes. The company was founded in 2004 with the vision of bringing innovative new technologies to ophthalmologists and transforming existing standards of care. Since its founding, OptiMedica has been developing a reproducible, noninvasive technique to replace the inconsistent manual steps in cataract surgery with femtosecond laser technology. The system has been designed to deliver new levels of precision, control, performance, and efficacy to cataract surgeons and their patients. OptiMedica has completed clinical trials of its Catalysâ„¢ Precision Laser System, with very promising results reported across these measures. While the Catalys Precision Laser System is not currently for sale in the United States, OptiMedica expects to launch the system in U.S. and international markets in 2011.

ReVision Optics, Inc. designs, manufactures, and delivers implantable products for the treatment of presbyopia. It offers PRESBYLENS Corneal Inlay, a refractive surgery solution to correct vision lost by the natural aging process called presbyopia. The company serves the ophthalmology professionals. ReVision Optics, Inc. was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in 2005. The company was founded in 1996 and is based in Lake Forest, California.

The USC Incubator accelerates the development of USC’s top student and alumni entrepreneurs through experiential education, mentorship and community. The USC Incubator, supported by the Greif Center for Entrepreneurial Studies at USC’s Marshall School takes founders from feasibility and development work, on to customers, a tested business model, getting distribution, building a team, bootstrapping and investment preparation. They also provide access to other supporting resources, such as legal and financial assistance.

KeraVision engages in the development of a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia, and astigmatism, to offer an alternative to eyeglasses, contact lenses, and other vision correction surgical procedures. Its first product, intacs corneal ring segments, has been approved by the FDA for correcting mild myopia in the range of -1.0 to -3.0 diopters in patients who are 21 years of age or older, who have a stable refraction, and who have up to +1.0 diopter of astigmatism. It is currently conducting a Phase III clinical trial to expand its approved range of indication for myopia to include -0.75 to -1.0 diopter and -3.1 to -4.5 diopters.

GenoTech Corp. engages in the production, sales of biotechnology related products and in provision of technical and academic services. It operates through the following business areas: Bio, Gene Synthesis, and Genetic Analysis. The Bio business area offers bio-technology based products and services for improvement of human health, disease prevention, diagnosis and treatment. The Gene Synthesis business area provides products used for biotechnology research and development such as oligonucleotides, enzymes, cloning technology kits and others. The Genetic Analysis business area offers genome analytic and genome sequencing services. The company was founded on July 8, 1997 and is headquartered in Daejeon, South Korea.

Zhongshan Ophthalmic Center, part of Sun Yat-Sen University, is a Chinese company located in Guangzhou that operates hospitals.

Shenyang He's Eye Hospital Co., Ltd., established on 2015-11-12, Business scope includes licensed projects:medical service,Class III medical device business,Drug retail,publication retail,Publications Internet Sales,Catering Services,Internet Information Service for Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Sales of Class I Medical Devices,Sales of Class II Medical Devices,glasses sales(Contact lenses not included),food sales(Only sell prepackaged food),Food Internet Sales(Only sell prepackaged food),Healthy food(prepackaged)Sales,Sales of hygiene products and single-use medical products,Sales of formula food for special medical purposes,Cosmetics Retail,Daily necessities sales,Watch sales,Stationery retail,Household Appliances Retail,Home Appliance Sales,Retailing of computer software, hardware and auxiliary equipment,Lighting sales,housing lease,Educational Consulting Services(Education and training activities that do not include licensing approval),Science popularization service,Disinfectant sales(Free of Hazardous Chemicals),electronics sales,Wearable smart device sales,internet sales(Except for products that require a license for sale),Health Consulting Services(Does not include medical services),Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Counseling Services,Import and export agency(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

GEUDER AG manufactures ophthalmic surgical instruments and systems. Its products include eye specula, retractors, foreign body instruments, scissors, forceps, needle holders and sterilization containers and adapters. The company was founded by Hans Geuder, Sr. in 1951 and is headquartered in Heidelberg, Germany.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.